The Cooper Companies, Inc.

COO

$70.22

Name : The Cooper Companies, Inc.

Sector : Healthcare

Industry: Medical Instruments & Supplies

Mark. Cap: $13,960,880,128.00

EPSttm : 2.04

The Cooper Companies, Inc.

$70.22

1.74%

$1.20

Float Short %

3.16

Margin Of Safety %

Put/Call OI Ratio

0.5

EPS Next Q Diff

-0.09

EPS Last/This Y

2.12

EPS This/Next Y

0.31

Price

69.03

Target Price

Analyst Recom

1.95

Performance Q

-7.91

Relative Volume

0.7

Beta

1.02

Ticker: COO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	COO	68.76	0.66	0.54	9346
2025-09-09	COO	68.24	0.66	0.11	9438
2025-09-10	COO	67.74	0.62	0.03	9900
2025-09-11	COO	68.46	0.65	1.04	9599
2025-09-12	COO	66.68	0.63	0.23	9684
2025-09-15	COO	65.52	0.60	0.93	10118
2025-09-16	COO	65.15	0.61	0.15	10374
2025-09-17	COO	64.32	0.58884644766998	0.14126394052045	10399
2025-09-18	COO	67.21	0.59	0.14	10330
2025-09-19	COO	68.14	0.58	0.34	10463
2025-09-22	COO	68.02	0.50	0.62	6947
2025-09-23	COO	67.48	0.50	0.41	7148
2025-09-24	COO	68.32	0.50	0.27	7174
2025-09-25	COO	66.87	0.51	0.30	7129
2025-09-26	COO	67.53	0.52	0.15	7123
2025-09-29	COO	67.64	0.52	3.92	7105
2025-09-30	COO	68.56	0.51	0.40	7137
2025-10-01	COO	68.06	0.51	0.13	7182
2025-10-02	COO	69.15	0.50	0.14	7241
2025-10-03	COO	70.46	0.50	0.24	7265
2025-10-06	COO	70.08	0.50	0.17	7250
2025-10-07	COO	69.03	0.50	0.16	7276
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	COO	68.79	7.2	124.4	4.09
2025-09-09	COO	68.23	7.2	111.3	4.09
2025-09-10	COO	67.67	7.2	111.0	4.09
2025-09-11	COO	68.46	7.2	125.5	4.09
2025-09-12	COO	66.68	7.2	98.5	4.09
2025-09-15	COO	65.46	7.2	104.0	4.09
2025-09-16	COO	65.16	7.2	113.6	4.09
2025-09-17	COO	64.34	7.2	108.1	4.09
2025-09-18	COO	67.21	7.2	148.9	4.09
2025-09-19	COO	68.14	7.2	126.7	4.09
2025-09-22	COO	68.00	7.2	115.3	4.09
2025-09-23	COO	67.50	7.2	111.8	4.09
2025-09-24	COO	68.35	7.2	126.0	4.09
2025-09-25	COO	66.89	7.2	101.8	4.09
2025-09-26	COO	67.55	7.2	124.1	4.09
2025-09-29	COO	67.64	7.2	118.0	4.09
2025-09-30	COO	68.54	7.2	126.2	4.09
2025-10-01	COO	68.07	7.2	112.0	4.09
2025-10-02	COO	69.11	7.2	127.9	4.09
2025-10-03	COO	70.45	7.4	130.8	4.09
2025-10-06	COO	70.11	7.4	127.3	4.09
2025-10-07	COO	69.03	7.4	106.0	4.09
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	COO	1.23	0.99	3.52
2025-09-09	COO	1.23	0.99	3.52
2025-09-10	COO	1.23	0.99	3.52
2025-09-11	COO	1.23	0.99	3.33
2025-09-12	COO	1.23	0.99	3.33
2025-09-15	COO	1.23	0.98	3.33
2025-09-16	COO	1.23	0.98	3.33
2025-09-17	COO	1.23	0.98	3.33
2025-09-18	COO	1.23	0.98	3.33
2025-09-19	COO	1.23	0.98	3.33
2025-09-22	COO	1.23	1.00	3.33
2025-09-23	COO	1.23	1.00	3.33
2025-09-24	COO	1.23	1.00	3.33
2025-09-25	COO	1.23	1.00	3.16
2025-09-26	COO	1.23	1.00	3.16
2025-09-29	COO	1.23	1.00	3.16
2025-09-30	COO	1.39	1.00	3.16
2025-10-01	COO	1.39	1.00	3.16
2025-10-02	COO	1.46	1.00	3.16
2025-10-03	COO	1.46	1.00	3.16
2025-10-06	COO	1.46	1.01	3.16
2025-10-07	COO	1.46	1.01	3.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.1

Avg. EPS Est. Current Quarter

1.12

Avg. EPS Est. Next Quarter

1.01

Insider Transactions

1.46

Institutional Transactions

1.01

Beta

1.02

Average Sales Estimate Current Quarter

1063

Average Sales Estimate Next Quarter

1023

Fair Value

84.01

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

40.4

Max Drawdown 5-Year %

-45.4

Target Price

P/E

33.98

Forward P/E

15.66

PEG

3.65

P/S

3.39

P/B

1.64

P/Free Cash Flow

33.31

EPS

2.03

Average EPS Est. Cur. Y

4.09

EPS Next Y. (Est.)

4.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.08

Relative Volume

0.7

Return on Equity vs Sector %

-20.3

Return on Equity vs Industry %

-3.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

106

The Cooper Companies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 16000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today

news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance

stock history COO – The Cooper Companies, Inc. invest stock market

stock prices COO premarket after hours

ticker COO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: COO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y